Ebol, Gregorio M.

HRN: 24-38-29  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/11/2024
01/17/2024
IV
1.5g
Q6h
CAP MR
Checking Final Appropriateness 
01/11/2024
AZITHROMYCIN 500MG TABLET (TAB)
01/11/2024
01/15/2024
ORAL
500mg
OD
Cap Mr
Checking Final Appropriateness 
01/16/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/16/2024
01/22/2024
IV
4.5 Grams
Q 8 Hours
Cap
Checking Final Appropriateness 
01/25/2024
CEFTRIAXONE 1G (VIAL)
01/25/2024
02/01/2024
IV
2 Gram
Once A Day
Deescalation From Piperacillin-Tazobactam
Waiting Final Action 
02/12/2024
LEVOFLOXACIN 500MG (TAB)
02/12/2024
02/18/2024
PO
500mg
OD
CAP-MR; S/P CTT Right For Pleural Effusion
Waiting Final Action 
02/18/2024
CEFTAZIDIME 1GM (VIAL)
02/18/2024
02/25/2024
IVT
1gm
Q8
Post Ctt Site Infection
Waiting Final Action 
02/19/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/19/2024
02/26/2024
IV
600
Q6
Infected CTT Site
Waiting Final Action 
02/19/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/19/2024
02/26/2024
IV
600
Q6
Infected CTT Site
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: